🦊/Investors

Dolby Family Ventures

Family officeoperating company · company profile

San Francisco · Pre-Seed–Series A · 21 people tracked

Also known as DOLBY FAMILY CAPITAL MANAGEMENT LLC · DOLBY FAMILY VENTURES LLC

Find your way into Dolby Family Ventures

2,916 people in our graph share verified history with the Dolby Family Ventures team — schools, employers, funds. One of them is your warm intro.

Deep Nisharunlockedknows Lin Ning · together at Stanford University (overlapped)
×4knows the team · via Stanford University
knows the team · via Harvard University
knows the team · via Credit Suisse
×4knows the team · via Kauffman Fellows
knows the team · via University of California, Berkeley
Fox Verdict
Sign up to see your fit

Investment thesis

The firm invests in life sciences across two pillars: precision neuroscience and life sciences platforms. In precision neuroscience, it funds diverse approaches spanning neurodegeneration, psychiatry, and neurotech, focusing on disease-modifying therapeutics while also backing therapeutics, devices, and diagnostics. In life sciences platforms, it supports companies transforming how medicines are discovered, developed, and delivered, including de novo platforms, regenerative medicine, computational biology, and provider operations. Central to its strategy is a polymedicine approach to treating complex diseases that impose significant burdens on patient mortality, morbidity, and quality of life. It does not currently invest in non-platform companies in oncology, cardiovascular, or rare diseases.

Source: firm website, verified Sep 15, 2026.

Stage
Pre-Seed–Series A
HQ
San Francisco, CA, US
Leads rounds
Follows
Instruments
Equity
Founded
2014
Last 12 months
2 investments
Private fund assets
$103.7M
VC funds
2
Tracked investments
93
Unicorns
3
IPOs
2
Acquisitions
4

Team · 21 people

from the firm's website & curated & public directories
Reetika Bhardwaj, PhD· Principalin
Alona Cochran· Office Manager & Executive Assistantin
Edward Chang, MD· Scientific Advisory Board
Howard Fillit, MD· Scientific Advisory Board
Husseini Manji, MD· Scientific Advisory Board
Lennart Mucke, MD· Scientific Advisory Board
Lin Ning, PhD· Senior Associate
Maurizio Fava, MD· Scientific Advisory Board
Mei Liang· Vice President, Financein
Michael Weiner, MD· Scientific Advisory Board
Rudolph E. Tanzi, PhD· Scientific Advisory Board
Usua Amanam, PhD· Senior Associatein

What they invest in

from 78 of 93 portfolio companies

Biotech ×38AI & Machine Learning ×29Deep Tech ×29Healthtech ×24Medical Devices ×21Hardware ×15Digital Health ×14SaaS ×10

HQs:United States×57Austria×1Australia×1Switzerland×1Germany×1

Investments · 93 tracked

founders shown can be your intro path

By year:2025 · 52024 · 42023 · 62022 · 12021 · 52020 · 22019 · 42018 · 22017 · 12016 · 12015 · 22014 · 235 dated

Hyperfinehyperfine.ioin𝕏NASDAQ: HYPR

Hyperfine develops diagnostic imaging and data solutions for patient care.

AI & Machine LearningDeep TechHealthtechMedical Devices

Jonathan Rothberg(Founder)Maria Sainz(President, Chief Executive Officer and Director)Brett Hale(Chief Administrative Officer, Chief Financial Officer, Treasurer and Corporate Secretary)Thomas Teisseyre(Chief Operating Officer)

Co-investorsAltium CapitalColle Capital Partners

Talkspacetalkspace.comin𝕏NASDAQ: TALK

Talkspace is an online mental health care platform that provides research-backed therapy and psychiatric services covered by insurance, allowing users to connect with licensed therapists and psychiatrists through text, audio, or video.

Digital HealthHealthtechMental Health

Oren Frank(Founder)inJon Cohen, M.D.inJon Cohen(Chief Executive Officer and Director)in

Co-investorsCompoundHDS CapitalQumra CapitalRunway Venture PartnersVillage GlobalAlpine Ventures+13 more

AccuKnox Risk-Adjacentaccuknox.comin𝕏✓ verified

AccuKnox provides automated adversarial testing for large language models, machine learning models, and cloud AI infrastructure to detect security vulnerabilities including prompt injection, jailbreaks, hallucinations, and misconfigurations.

AI & Machine LearningCloud ComputingCybersecurityEnterprise Software

Rahul Jadhav(Founder)in

Co-investorsAvanta VenturesDreamit VenturesNational Grid PartnersMDSV CAPITALOutliers VCZ5 Capital

cloudclouddefense.aiin𝕏✓ verified

AccuKnox provides an Application Security Posture Management (ASPM) platform that integrates vulnerability management, static and dynamic application security testing, software composition analysis, and infrastructure-as-code scanning to identify and prioritize security risks across the software development lifecycle for development and security teams.

AI & Machine LearningCloud ComputingCybersecurityDeveloper ToolsEnterprise Software

Co-investorsAvanta VenturesDreamit VenturesNational Grid PartnersSparq Capital (SFO)

Kuprion Inckuprioninc.comin✓ verifiedAcquired

Kuprion develops ActiveCopper materials and printable conductive inks used to manage heat in high-power, high-temperature electronic systems, serving electronics engineers and manufacturers across industries including semiconductor packaging, electric vehicles, and 5G communications.

HardwareNew MaterialsSemiconductorsSan Jose, US

Dr. Alfred Zinn(Founder)in

Co-investorsAlsop Louie Partners

Neurotherapianeurotherapia.comin✓ verified

NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCleveland, US

Co-investorsBrain Trust Accelerator Fund

Twelvetwelve.coin𝕏Apr 2015✓ verified

Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.

Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US

Nicholas Flanders(Founder & CEO)inEtosha Cave(Founder)inKendra Kuhl(Founder)inAndrew Cleeland(Executive Officer, Director)in

BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)

Co-investorsBreakout VenturesDCVC (Data Collective)Fifth WallAdvantage Partners Inc.Aera VCCantos Ventures+24 more

Vandriavandria.comin✓ verified

Vandria is a pharmaceutical development company focused on translating scientific innovation into first-in-class therapeutics.

BiotechHealthtechLongevityMedical DevicesLausanne, CH

Patrick Aebischer(Co-founder)Pénélope Andreux(Head of Research (mitochondrial research and development))inKlaus Dugi(Chief Medical Officer / Medical Leadership)inPeter(Business Development & Entrepreneurship Leadership)Leila(Operations Leadership)Anke Post(Chief Medical Officer / Neuroscience Leadership)

Co-investors+ND CapitalApollo Health Ventures

▶︎ CYTOVALEcytovale.comin𝕏

Cytovale develops microfluidic deformability cytometry technology for immune response diagnostics, with a focus on early detection and diagnosis in hospital settings.

BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Ajay Shah(Co-founder & CEO)inHenry Tse(Co-founder & Chief Technology Officer)inDino DiCarlo(Director, Promoter)

BoardLindy Fishburne(Director)inJack Fuchs(Director, Promoter)in

Co-investorsAlumni VenturesBasecamp FundBlackhorn VenturesBreakout LabsBreakout VenturesEMV Capital+3 more

3Scan3scan.comNov 2014

San Francisco, US

Todd Huffman(Executive Officer, Director)Megan Klimen(Executive Officer)

BoardJoshua Wolfe(Director)Matt Ocko(Director)inAdam Goulburn(Director)inAdam Goulborn(Director)

Co-investorsComet LabsDCVC (Data Collective)Dimension CapitalLux CapitalOS Fund

Acrigenacrigen.cominJun 2019

Acrigen develops precision gene editing systems based on CRISPR, using novel αCas and μCas nuclease libraries paired with engineered anti-CRISPR (ErAcr) proteins to reduce off-target edits.

BiotechDeep TechHealthtechKensington, US

Joseph Bondy-Denomy(Director)David Rabuka(Executive Officer, Director, Promoter)Karen Boezi(Director)

Co-investorsBerkeley Catalyst

Aether Bioaetherbio.comin𝕏

Aether develops additives that blend into engineering-grade nylons to enable faster, high-throughput fused filament (FFF/FDM) 3D printing while maintaining mechanical strength and dimensional accuracy.

Advanced ManufacturingAI & Machine LearningBiotechDeep TechHardwareNew Materials

Pavle Jeremic(Founder & CEO)inJay Zaveri(Co-Founder & President)

Co-investors4DX VenturesAbstract VenturesArtis VenturesBlue Bear VenturesBoxGroupCalm Ventures+11 more

Allall.health

all.health offers an Integrated Continuous Management (ICM) platform combining a clinical-grade wearable with an FDA-recognized system that collects 24/7 vitals and biometrics, screens for disease risk, and links patients to their care teams.

AI & Machine LearningDigital HealthHealthtech

Co-investorsMindset VentureSignalFireMorpheus VenturesReinvent Capital

Athiraathira.com

A biotechnology company developing new therapies for patients with high unmet medical needs.

Biotech

Co-investorsSofinnova Ventures

Atmosicatmosic.comin𝕏Dec 2019 · $28.5M

Atmosic designs ultra-low-power wireless connectivity and compute chips for connected devices, aiming to extend battery life or enable battery-free operation.

HardwareIoTSemiconductorsCampbell, US

David Su(Founder)inMasoud Zargari(Founder)in

Co-investorsClear VenturesSutter Hill VenturesWalden International

Atomwiseatomwise.comin

Atomwise uses artificial intelligence and machine learning to discover novel small-molecule drugs, with a current focus on developing treatments for immune and inflammatory diseases.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Izhar Wallach(Executive Officer, Director)inAbraham Heifets(Executive Officer, Director, Promoter)Yan Zhao(Executive Officer)inStephen Worland(Executive Officer, Director)

BoardRobert Mittendorff(Director)inAdam Seabrook(Director)in

Co-investorsAurum Venture PartnersB Capital GroupCerity Partners VenturesCreative Destruction Lab (CDL)Draper AssociatesThreshold Ventures+6 more

Authentic Visionauthenticvision.cominFeb 2023 · $5M

Authentic Vision provides secure product digitalization solutions using holographic fingerprint technology and smartphone-based authentication to create copy-resistant product identities.

Advanced ManufacturingAI & Machine LearningCircular EconomyCybersecurityDeep TechEnterprise SoftwareFintechHardwareSaaSSalzburg, AT

Co-investorsJoint EffectsSmart Family Office

Cajalneurocajalneuro.comin

Cajal Therapeutics is a biotech company developing novel therapies through the translation of neuroscience research into therapeutic treatments for patients.

BiotechDeep TechDigital HealthSeattle, US

Andrew Dervan(Co-Founder and Co-Chief Executive Officer)inIan Peikon(Co-Founder and Co-Chief Executive Officer)inRob Hershberg(Co-Founder and Executive Chairman)in

Co-investorsLux Capital

Calacalahealth.comin𝕏

Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor.

Deep TechDigital HealthHealthtechMedical DevicesSilicon Valley, US

Kate Rosenbluth, PhD(President & Chief Innovation Officer)Kate Rosenbluth(Founder)inDeanna Harshbarger(Chief Executive Officer)in

Co-investorsAlumni VenturesAscension VenturesGlobal BrainGV (Google Ventures)Lightstone VenturesLux Capital+3 more

Calicatcalicat.comOct 2024 · $3M

California Catalysts develops advanced materials and catalysts for hydrogen electrolysis using AI-driven discovery methods.

AI & Machine LearningCleantechEnergyNew MaterialsLos Angeles, US

Jim DiSanto(Co-founder, Board Director, Executive Consultant)inJourdan Urbach(CEO)

BoardNathan Lewis(Founder; Chief Scientific Advisor)

Co-investorsAcario InnovationMOL SwitchTSVCVoLo Earth VenturesMotus Ventures, Llc

Canaerycanaery.comin

Canaery develops a nose-computer interface that combines animal olfaction with neurotechnology and AI to detect substances and diagnose diseases.

AI & Machine LearningBiotechDeep TechHardwareMedical Devices

Gabriel(Chief Executive Officer)Peter(Chief Technology Officer)

BoardDmitry(Chief Science Advisor)

Co-investors15th RockGood News VenturesBreakout VenturesKdT Ventures

Cato Digitalcato.digitalin𝕏

Cato Digital builds a bare metal cloud platform focused on maximizing data center capacity utilization through low-cost, low-carbon computing solutions.

AI & Machine LearningCleantechCloud ComputingData & InfrastructureDeep Tech

Co-investorsCowles Ventures

Cerevancecerevance.comin𝕏

Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US

Craig Thompson(Chief Executive Officer)inSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)Mark Carlton(Chief Scientific Officer)inOttavio V. Vitolo(Chief Medical Officer)in

Co-investorsForesite CapitalGV (Google Ventures)Dementia Discovery FundSV Life SciencesDementia DiscoveryLightstone Ventures+3 more

Cognition Therapeuticscogrx.comin𝕏

Cognition Therapeutics is a clinical-stage biotechnology company developing zervimesine (CT1812), an investigational once-daily oral small-molecule therapy designed to protect brain synapses by blocking toxic protein oligomers.

BiotechHealthtechPittsburgh, US

Susan Catalano(Executive Officer, Director)inSusan Catalano, Ph.D.(Co-founder)Lisa Ricciardi(Chief Executive Officer)inHarold Safferstein(Executive Officer, Director)

BoardNada Jain(Director)Franz Hefti(Director)

Co-investors3E Bioventures CapitalAtlanta Technology AngelsHouston Angel NetworkiNetworksGolden Seeds

Cognitive Spacecognitivespace.comin𝕏Seed · Oct 2023 · $4M

Cognitive Space develops AI-driven automation software for satellite operations, enabling constellation operators to scale while meeting operational requirements.

AI & Machine LearningDefense TechSaaSSpace TechHouston, US

Marc Bell(Co-Founder and CEO)Guy de Carufel(CEO & Founder)inDax Garner(CTO)inJeff Edwards(VP of Engineering)inHanna Steplewska(Executive Officer, Director)Jennifer Roberts(Director)in

Co-investorsCapital InnovatorsCreative Destruction Lab (CDL)Draper AssociatesGlasswing VenturesGrit VenturesGutbrain Ventures+8 more

Cquestacquesta.comin

Cquesta develops crop varieties with enhanced root systems to increase agricultural productivity and sequester carbon in soil.

AgTechBiotechCleantechClimate Tech

Andrew Baum(CEO)Tim Ulmasov(President and CSO)

Co-investorsBezos Earth Fund

Delixdelixtherapeutics.cominSep 2021 · $70M

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

Co-investorsArtis VenturesCasa Verde CapitalNoeticOMX VenturesPsyMed VenturesRA Capital+6 more

Diamond Agediamondage3d.comin

Robotic systems and 3D printing company innovating at industrial scale to transform homebuilding.

Co-investorsPerot JainSuffolk TechnologiesAlpaca VCCalm VenturesGaingelsPrime Movers Lab+1 more

DigiLendsdigilens.comin𝕏Apr 2018

DigiLens develops waveguide optics and holographic display technology using a proprietary material set combined with inkjet printing and a holographic contact copy process.

Deep TechHardwareNew MaterialsSunnyvale, US

Jonathan Waldern(Director)inChristopher Pickett(Executive Officer, Director)Patrick Suel(Director)Robert Young(Director)Thorsten Alexander Kern(Director)

BoardJim Whims(Director)

Co-investorsAlsop Louie PartnersBold Capital PartnersDiamond Edge VenturesNautilus Ventures Management Company (Us), LlcSony Ventures CorporationMITSUBISHI CHEMICAL+1 more

Eargoeargo.comDec 2018Defunct

Eargo was a hearing aid company that provided high-quality hearing aids and related care services.

HealthtechMedical DevicesMountain View, US

Raphael Michel(Executive Officer, Director)Christian Gormsen(Executive Officer, Director)William Brownie(Executive Officer)Peter Tuxen Bisgaard(Director)

BoardDavid Wu(Director)inJosh Makower(Director)

Co-investorsBirchmere VenturesLongitude CapitalMaveronNew Enterprise Associates (NEA)Montage VenturesPatient Square Capital+1 more

EnClear Therapiesencleartherapies.cominFeb 2024

EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in

Co-investors20/20 HealthCare Partners LLCFlucas VenturesTachyon VenturesVU Venture PartnersAmgen VenturesFounders Fund

Envisagenicsenvisagenics.cominSep 2021

Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.

AI & Machine LearningBiotechMedical DevicesNew York, US

Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Executive Officer, Director, Promoter)inMaria Luisa Pineda(Executive Officer, Director, Promoter)inMaria Luisa Pineda, PhD.(Founder)in

Co-investorsDynamk CapitalHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationThird Kind Venture Capital

Esper Satellite Imageryespersatellites.coin𝕏

Esper provides hyperspectral satellite imagery and geochemical analysis to identify critical minerals and alteration zones for mining exploration and environmental monitoring.

AgTechDeep TechSpace TechPatterson Lakes, AU

JoeyShoaib Iqbal(Chief Executive Officer)inPrzemyslaw Lorenczak(Chief Technology Officer)

Co-investorsCroc PitchNZVCTechstars

Genemodgenemod.netin𝕏Aug 2020 · $4.5M

Genemod offers a lab management platform that combines electronic lab notebook (ELN), LIMS, inventory, and equipment tracking in one data model, with AI agents that plan experiments, execute protocols across connected systems, and generate audit-ready records.

AI & Machine LearningBiotechHealthtechSaaSEdmonds, US

Jacob Lee(Executive Officer, Director, Promoter)inZachary Gut(Director)Michael Gregoire(Director)Jin Choe(Director, Promoter)Anil Arora(Executive Officer)

BoardNeil Sequeira(Director)in

Co-investorsAmino CapitalDefy Partnersfutureland venturesLDV Partners

ICON Aircrafticonaircraft.com𝕏Mar 2019

ICON Aircraft designs, builds, and certifies Light-Sport Aircraft, notably the ICON A5, and offers customer sales, service, and flight training.

Advanced ManufacturingHardwareMobility & TransportationVacaville, US

Kirk Hawkins(Executive Officer, Director)Rich Bridge(Executive Officer)Thomas Wieners(Executive Officer)Katherine DeHoff(Executive Officer)Rodolfo (Rudy) Correa(Vice President, Operations)Amy Xu(Interim CFO & Corporate Secretary)

Co-investorsSeraph Group

Kebotixkebotix.comin𝕏

Kebotix uses artificial intelligence, machine learning, and laboratory automation to discover and develop new materials and molecules.

AI & Machine LearningDeep TechNew MaterialsCambridge, US

Dennis Sheberla(Executive Officer)inSemion Saykin(Executive Officer)Alan Aspuru-Guzik(Executive Officer)inAshish Kulkarni(Executive Officer, Director)in

BoardTong Hui(Director)Andrew Krowne(Director)in

Co-investorsArcTern VenturesBantam GroupFlybridge Capital PartnersOne Way VenturesPropagator VenturesSafar Partners+4 more

Leo Labsleolabs.spacein𝕏

LeoLabs operates a network of ground-based radars and an AI-enabled cloud platform that tracks and maps objects and activity in low Earth orbit.

AI & Machine LearningDefense TechSpace Tech

Daniel Ceperley(Founder)in

Co-investorsHemisphere Ventures LLCMDSV CAPITALNZ Growth Capital PartnersSeraphim SpaceSpace CapitalSparq Capital (SFO)+3 more

Libra Therapeuticslibratherapeutics.comin𝕏

Libra Therapeutics develops small molecule therapeutics targeting lysosomal function and autophagy to treat neurodegenerative diseases including ALS, Parkinson's, Alzheimer's, and Huntington's disease.

BiotechLongevityMedical Devices

Dr. Gill(Chief Scientific Officer)

Co-investorsEpidarex CapitalAMR Action Fund

Lightformlightform.comin𝕏Seed · Nov 2017 · $5M

Lightform develops design tools for projected augmented reality, combining computer vision and hardware to enable interactive visual experiences.

AI & Machine LearningDeep TechDeveloper ToolsHardware

Co-investorsComet LabsCrunchFundPresence CapitalTuesday CapitalAnorak VenturesLevensohn Venture Partners+2 more

Magnefymagnefy.comin

Magnefy develops hybrid magnetic sensing and signal-processing hardware combined with AI/ML for monitoring critical infrastructure in harsh, real-world environments.

Deep TechHardwareIoTPalo Alto, US

Joseph Kao(CEO & Co-Founder)inDerrick Du(Founding Product Manager)inAsma Mahar(Head of Hardware - Sensors & Signal Processing)in

Co-investorsSunna VenturesDangerous Ventures

magnusmagnusmed.comin𝕏Feb 2025

Magnus Medical develops SAINT, an FDA-cleared, accelerated form of TMS (transcranial magnetic stimulation) therapy that uses precision neuromodulation to treat Major Depressive Disorder, including treatment-resistant depression, over a 5-day course.

BiotechDigital HealthMedical DevicesMental HealthBurlingame, US

Nolan Williams(Director)Christian Gormsen(Executive Officer, Director)inVikram Lamba(Executive Officer)in

BoardXingjuan Chao(Director)inAndrew Firlik(Director)inHeath Lukatch(Director)

Co-investorsJAZZ Venture PartnersRed Tree Venture

Medcryptmedcrypt.comin𝕏

Medcrypt provides cybersecurity products and strategic consulting to medical device manufacturers to ensure their devices are secure by design and meet FDA regulatory requirements.

CybersecurityHealthtechMedical Devices

Mike Kijewski(Founder)in

Co-investorsEniac VenturesIntuitive VenturesSection 32Y Combinator

Mojo Visionmojo.visionin𝕏

Mojo Vision develops micro-LED technology, positioning it as a platform for AI infrastructure and next-generation displays.

Deep TechHardwareSemiconductors

Nikhil Balram(Chief Executive Officer)inMike Wiemer(Chief Technology Officer)inG. Aaron James(General Counsel)in

BoardSteve Jurvetson(Founder)in

Co-investorsARC Angel FundArgonautic VenturesBold Capital PartnersDisney AcceleratorFlucas VenturesFusion+15 more

Montara Therapeuticsmontaratx.comin

Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.

AI & Machine LearningBiotechDeep TechSan Francisco, US

Kevan Shokat(Co-Scientific Founder & Chairman of the SAB)Thomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)

Co-investorsBEVCSV Health InvestorsTwo Bear CapitalDementia Discovery FundKdT Ventures

Monument Biosciencesmonument.bioin

Monument Biosciences is a biotechnology company developing disease-modifying drugs for Alzheimer's Disease and Related Dementias (ADRD).

BiotechDigital Health

Co-investorsElevate Ventures

Moovemoove.aiinMar 2023

Moove.ai applies machine learning to real-time connected vehicle data to assess transportation risk and build mitigation tools focused on road safety and efficiency.

AI & Machine LearningData & InfrastructureMobility & TransportationLafayette, US

Rafay KhaninJack Greco(Director)inSalman Dhanani(Director)Abdur Rafay Khan(Executive Officer, Director)

BoardLauren Deluca(Director)in

Co-investorsCortado VenturesMotivate Venture CapitalService Provider CapitalUber

Motif Neurotechmotifneuro.techin𝕏Jan 2024 · $19M

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)in

BoardJacob Robinson(Co-founder & CEO)in

Co-investorsArboretum VenturesFeatures Capital HoldingsPsyMed VenturesTMC Venture FundXEIA Venture PartnersCapital Factory+4 more

NeuroBionicsneurobionics.ioinNov 2025

NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.

BiotechDeep TechHealthtechMedical DevicesSomerville, US

MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)in

Co-investorsFuture VenturesGreyMatterVanedge CapitalVanedge Capital Limited PartnershipXEIA Venture PartnersLIONHEART VENTURES

NextSensenextsense.ioin

NextSense makes Smartbuds, EEG earbuds with dry-contact sensors that measure brain activity and adapt audio in real time to increase deep sleep, meditation, and focus.

Digital HealthHardwareWellness & FitnessMountain View, US

Jonathan Berent(Founder)inBradley Horowitz(Director)

BoardJohn Kuelper(Director)QuHarrison Terry(Director)

Co-investorsAscension VenturesGV (Google Ventures)Prime Movers Lab

Nianticnianticlabs.comacquired by Scopely, Inc.

Niantic Labs develops mobile games and apps that encourage outdoor exploration and real-world community engagement through location-based gaming experiences.

ConsumerGamingSan Francisco, US

John Hanke(Executive Officer, Director)

BoardKenji Okubo(Director)

Co-investorsAir Street CapitalAloft VCBonfire VenturesBreyer CapitalCapitalGCauseway Partners+12 more

Niantic Spatialnianticspatial.comin𝕏May 2025

Niantic Spatial builds real-world foundation models for physical AI, offering capabilities to reconstruct geometrically accurate 3D digital twins, localize devices without relying on GPS via a Visual Positioning System, and interpret 3D environments.

AI & Machine LearningDeep TechRoboticsSan Francisco, US

John Hanke(Executive Officer, Director)inKatherine Richard-Dodson(Executive Officer)Christopher Chow(Executive Officer)Thomas Gewecke(Executive Officer)in

BoardGilman Louie(Director)inMegan Quinn(Director)

Co-investorsAlsop Louie PartnersJavelin Venture PartnersScopely

OKAPI:Orbitsokapiorbits.spacein

OKAPI:Orbits provides AI-based Space Traffic Management (STM) and Space Situational Awareness (SSA) software platforms along with consulting services for satellite operators.

AI & Machine LearningSaaSSpace TechBraunschweig, DE

Kristina Nikolaus(Founder)in

Co-investorsAmadeus Capital PartnersAPEX VenturesMatterwave VenturesHeadlineMunich Re VenturesVentech

Paradromics Turning Data Into Medicineparadromics.comin𝕏

Paradromics develops a brain-computer interface (BCI) system, with FDA Breakthrough Device Designations for speech decoding and digital device control, and works with academic medical institutions on translational BCI research.

BiotechDeep TechHealthtechMedical DevicesAustin, US

Matt Angle(Founder and CEO)in

Co-investors15th RockAlpha EdisonAnthropy PartnersCapital FactoryCoastCapFrontier Path VC+14 more

Pharmatrophixpharmatrophix.comin

Pharmatrophix is developing a small-molecule drug for Alzheimer's disease that acts upstream of amyloid, with Phase 2a trial imaging showing dose-dependent preservation of whole-brain connectivity.

BiotechHealthtechRaleigh, US

Frank M. Longo(Director)inAnne C. Longo(Executive Officer)in

BoardRobert Sims(Director)

Phase Fourphasefour.ioAcquired

Phase Four developed in-space electric and multi-mode satellite propulsion; its technology assets were sold in 2025.

Hawthorne, US

STEPHEN KISER(Executive Officer, Director)inSimon Halpern(Executive Officer, Director)

BoardStewart Alsop(Director)inTHOMAS J.A. LAVIN(Director)JAMES BRIDENSTINE(Director)

Co-investorsAlsop Louie PartnersIndustrious VenturesNew Science VenturesVeteran Ventures Capital

Potatopotato.aiinApr 2025 · $4.5M

Potato builds software that connects scientific research intent to laboratory execution, enabling research teams to accelerate the translation from experimental design to hands-on lab work.

AI & Machine LearningBiotechDeep TechSaaS

Merrit Savener(VP of Commercial)

Co-investorsAllen Institute for AI (AI2) IncubatorEnsemble VCAlumni VenturesBoost VCCPT CapitalDraper Associates+5 more

Progentos Therapeuticsprogentos.comMay 2024 · $65M

Progentos develops small-molecule therapeutics to stimulate myelin regeneration in multiple sclerosis patients by activating oligodendrocyte progenitor cells.

BiotechDeep TechMedical DevicesWatertown, US

Dmitrij Hristodorov(Director)inChristopher Loose(Executive Officer, Director)Sanjay Magavi(Executive Officer)Marc-Olivier Turgeon(Director)in

BoardAleks Radovic-Moreno(Director)inDan Janney(Director)

Co-investorsAlta PartnersLongwood FundMission BiocapitalService Provider CapitalForbion

Quralisquralis.comin𝕏Mar 2023

QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.

BiotechDeep TechMedical DevicesCambridge, US

Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in

Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalMitsui Global InvestmentSanofi VenturesSV Health Investors+7 more

Readysetpotatoreadysetpotato.comin

Potato builds software that bridges scientific research and laboratory execution, enabling research teams to move from hypothesis to experiment to learning faster by automating the manual processes between scientific intent and real-world lab work.

AI & Machine LearningBiotechDeep TechSaaS

Merrit Savener(VP of Commercial)

Co-investorsDraper AssociatesRoble VenturesEnsemble VC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AlzecaBeep NetworksBionautCortexymeDiscover EchoEcho LaboratoriesMindImmune TherapeuticsMixed DimensionsNativewavesSharrow EngineeringSoilactionTetra Discovery PartnersYumanity

Exits · 6

2 IPOs · 4 acquisitions · showing 3

HyperfineNASDAQ: HYPRTalkspaceNASDAQ: TALKNianticacq. by Scopely, Inc.

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Dolby Family Ventures made?
Dolby Family Ventures has 93 tracked investments, 6 of which have exited, including 6 dated in the last 24 months.
What stage does Dolby Family Ventures invest at?
Dolby Family Ventures invests at the Pre-Seed, Seed, Series A stages.
What sectors does Dolby Family Ventures focus on?
Dolby Family Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
Where is Dolby Family Ventures located?
Dolby Family Ventures is headquartered in San Francisco, US.
Does Dolby Family Ventures lead rounds?
Dolby Family Ventures typically participates in rounds rather than leading them.

Images

Dolby Family Ventures photoDolby Family Ventures photoDolby Family Ventures photoDolby Family Ventures photoDolby Family Ventures photoDolby Family Ventures photo

Co-investors · 20

Alsop Louie Partners

Alsop Louie Partners is a venture capital firm that invests in technology companies, emphasizing an approach it calls 'Venture Humanism' — backing accountable technologies designed with built-in safeguards to advance prosperity, equality, and longevity.

Lux Capital

Lux Capital is a venture capital firm that backs founders building transformative deep technologies, having been among the first investors in category-defining companies across AI, robotics, biotech, defense, and infrastructure.

$100K – $100M
SV Health Investors

SV Health Investors is a healthcare-focused investment firm that invests across multiple stages, geographies and healthcare sectors.

$1M – $20M
GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.

$250K – $50M
Sanofi Ventures

Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies focused on improving human health. It serves as Sanofi's entry point into the innovation ecosystem.

Both backed · 3
$5M
Norwest Venture Partners

Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.

$10M – $30M
General Catalyst

General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.

Both backed · 1
$30M
Founders Fund

Founders Fund is a venture capital firm that backs technology companies building transformative products.

Both backed · 1
$500K – $5M
Susa Ventures

Susa Ventures operates two early-stage technology funds that invest in companies leveraging data, network effects, and economies of scale.

Both backed · 1
$1M – $5M
Anorak Ventures

Anorak Ventures is a seed-stage venture firm founded in 2016 with offices in Los Angeles and San Francisco, backing pre-seed and seed companies building differentiated technology and helping them reach product-market fit and follow-on funding.

Both backed · 1
$25K – $400K
Presence Capital

Presence Capital is an early-stage investment firm focused on augmented reality (AR) and virtual reality (VR) startups, backing entrepreneurs building new ways to communicate, work, and play with these technologies.

Both backed · 1
$25K – $100K
Tuesday Capital

Tuesday Capital (formerly CrunchFund) is an early-stage venture capital firm that has backed founders since 2011, with a portfolio spanning hundreds of companies including numerous unicorns, IPOs and acquisitions.

Both backed · 1
8 more co-investors

Ultratech Capital PartnersCanaan PartnersGoat CapitalTeam8SR One Capital ManagementCity LightAdvent Life SciencesJMI Equity

Firms observed investing alongside Dolby Family Ventures, from public investor directories. Shared companies are the overlap with Dolby Family Ventures's recorded portfolio.

Similar investors

Featured in lists